Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Help Therapeutics)"
Count: 98
Selected: 0
NCT06340048Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
NCT05566600Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
NCT05223894Treating Heart Failure With hiPSC-CMs
NCT04982081Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
NCT03763136Treating Heart Failure With hPSC-CMs
NCT00090779Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
NCT00361257Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
NCT04050449Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
NCT01435018Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
NCT00811954Comparative Study of Three NNRTI-Sparing HAART Regimens
NCT06205602Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa
NCT06205589Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
NCT06031272Pausing Antiretroviral Treatment Under Structured Evaluation
NCT05985642Observational PIC Destination Cohort
NCT05156658Pharmacokinetic Interactions of ENG Subdermal Implants With Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA)
NCT04636437Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide
NCT04042740Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection
NCT03819114Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy
NCT03512210Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
NCT03070223PREPARE (A5361s) Substudy of REPRIEVE (A5332)
NCT03001128Biomarkers to Predict Time to Plasma HIV RNA Rebound
NCT02859558Early ART to Limit Infection and Establishment of Reservoir
NCT02706717Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers
NCT0260530412 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
NCT02582684Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients
NCT02513771Sitagliptin for Reducing Inflammation and Immune Activation
NCT02440789Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)
NCT02412436PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB
NCT02155985Modulation of Immune Activation by Aspirin
NCT02128217Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
NCT01969058Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery
NCT01936831High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)
NCT01928927Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)
NCT01903031Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART
NCT01777997FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir
NCT01641367A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
NCT01632891Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
NCT01601626Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
NCT01589497Essentiality of INH in TB Therapy
NCT01543958Sevelamer for Reducing Endotoxemia and Immune Activation
NCT01515813Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
NCT01466595Rifaximin as a Modulator of Microbial Translocation and Immune Activation
NCT01427738Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis
NCT01426438Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
NCT01403051High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
NCT01400412Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
NCT01380080REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
NCT01352715Study of Options for Second-Line Effective Combination Therapy (SELECT)
NCT01352117Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
NCT01351025Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells